Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Takeda
Company Monitoring Page for Takeda
latest headlines for company on cafepharma
Takeda's Ninlaro Met Primary Endpoint in Ph III Trial In Patients with Multiple Myeloma Post Stem Cell Transplant
CP Wire
Wed, 07/11/18 - 10:15 am
Tags:
Takeda
,
Ninlaro
,
Multiple Myeloma
FTC Clears Takeda's Acquisition of Shire
CP Wire
Tue, 07/10/18 - 11:46 am
Tags:
FTC
,
M&A
,
Takeda
,
Shire
More than $100 Billion Spent on M&A in the First 6 Months of 2018
BioSpace
Thu, 07/5/18 - 10:28 pm
Tags:
M&A
,
biotech
,
Celgene
,
Sanofi
,
Impact Biomedicines
,
Bioverativ
,
GSK
,
Takeda
,
Shire
,
JNJ
Takeda posts ‘for-sale’ sign on company’s ancestral home in Osaka in effort to fund Shire buyout
Endpoints
Thu, 07/5/18 - 10:50 am
Tags:
Takeda
,
Shire
,
M&A
,
Japan
Takeda shareholders bin proposal from anti-Shire group; only 10 percent in favor
Reuters
Thu, 06/28/18 - 07:15 pm
Tags:
Takeda
,
Shire
,
M&A
,
shareholders
Public Citizen Calls on FDA to Withdraw Takeda Gout Drug
RAPS.org
Thu, 06/21/18 - 10:51 pm
Tags:
Takeda
,
Public Citizen
,
gout
,
Uloric
Bitterly opposed old guard at Takeda wages a last-ditch fight to block ‘foreign blood’s’ $62B Shire buyout
Endpoints
Mon, 06/11/18 - 09:46 am
Tags:
Takeda
,
Shire
,
Christophe Weber
,
M&A
With $460B in borrowing capacity, will any of the Big-20 biopharmas go after one of the top-5 takeover targets?
Endpoints
Tue, 05/29/18 - 09:22 pm
Tags:
M&A
,
JNJ
,
Merck
,
Pfizer
,
Gilead Sciences
,
Amgen
,
Biogen
,
Takeda
,
Regeneron
,
Alexion
Takeda shareholders fear dilution, debt from Shire deal pose ‘high risks,’ demand shareholders vote on it
Fierce Pharma
Tue, 05/29/18 - 11:40 am
Tags:
Takeda
,
Shire
,
shareholders
,
M&A
Takeda makes $280M divestiture amid Shire buy
Biopharma Dive
Tue, 05/22/18 - 06:41 pm
Tags:
Takeda
,
Shire
,
M&A
,
Guangdong Techpool Bio-Pharma
Takeda CEO Sees Path to Survival in Shire Megadeal
Bloomberg
Thu, 05/17/18 - 10:25 pm
Tags:
Takeda
,
Shire
,
M&A
,
Pharma CEOs
,
Chris Weber
Will Shire’s top R&D talent bolt now that Takeda has struck a merger agreement?
Endpoints
Thu, 05/17/18 - 11:57 am
Tags:
Shire
,
Takeda
,
M&A
,
R&D
Takeda and Shire: A Pricey Marriage
Motley Fool
Mon, 05/14/18 - 11:22 pm
Tags:
Takeda
,
Shire
,
M&A
Janssen obtains FDA approval for Darzalex (multiple myeloma)
GoinPharma
Sun, 05/13/18 - 03:52 pm
Tags:
Janssen
,
JNJ
,
Darzalex
,
Takeda
,
Velcade
,
Multiple Myeloma
,
FDA
Whisky, secrets, and code names: behind-the-scenes of Takeda’s $62B Shire bid – Bloomberg
Endpoints
Fri, 05/11/18 - 10:35 am
Tags:
Takeda
,
Shire
,
M&A
Takeda to cut IT, marketing and sales jobs after Shire merger
Pharmaforum
Thu, 05/10/18 - 11:18 pm
Tags:
Takeda
,
Shire
,
M&A
,
layoffs
Takeda Finally Inks a Deal to Buy Shire in One of the Biggest Pharma Takeovers Ever
Fortune
Tue, 05/8/18 - 09:48 am
Tags:
Takeda
,
Shire
,
M&A
Takeda Nears Deal to Buy Shire in Its Biggest Purchase
Bloomberg
Mon, 05/7/18 - 09:59 pm
Tags:
Takeda
,
Shire
,
M&A
4 Huge Pharma Deals in 4 Months Is Just the Beginning
Motley Fool
Sat, 04/28/18 - 12:18 pm
Tags:
M&A
,
Takeda
,
Shire
,
Novartis
,
AveXis
,
Sanofi
,
Bioverativ
,
Celgene
,
Juno Therapeutics
Hey, Takeda shareholders: Shire's Q1 may ease some buyout worries, analysts say
Fierce Pharma
Thu, 04/26/18 - 09:53 pm
Tags:
Takeda
,
Shire
,
M&A
,
earnings
Pages
« first
‹ previous
…
16
17
18
19
20
21
22
23
24
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
a dog would most likely chase a: cat, rock, house
*
Fill in the blank.